Safety and efficacy of mechanical embolectomy in acute ischemic stroke: Results of the MERCI trial

Wade S. Smith, Gene Sung, Sidney Starkman, Jeffrey L. Saver, Chelsea S. Kidwell, Y. Pierre Gobin, Helmi L. Lutsep, Gary M. Nesbit, Thomas Grobelny, Marilyn M. Rymer, Isaac E. Silverman, Randall T. Higashida, Ronald F. Budzik, Michael P. Marks

Research output: Contribution to journalArticle

1066 Scopus citations

Abstract

Background and Purpose - The only Food and Drug Administration (FDA)-approved treatment for acute ischemic stroke is tissue plasminogen activator (tPA) given intravenously within 3 hours of symptom onset. An alternative strategy for opening intracranial vessels during stroke is mechanical embolectomy, especially for patients ineligible for intravenous tPA. Methods - We investigated the safety and efficacy of a novel embolectomy device (Merci Retriever) to open occluded intracranial large vessels within 8 hours of the onset of stroke symptoms in a prospective, nonrandomized, multicenter trial. All patients were ineligible for intravenous tPA. Primary outcomes were recanalization and safety, and secondary outcomes were neurological outcome at 90 days in recanalized versus nonrecanalized patients. Results - Recanalization was achieved in 46% (69/151) of patients on intention to treat analysis, and in 48% (68/141) of patients in whom the device was deployed. This rate is significantly higher than that expected using an historical control of 18% (P<0.0001). Clinically significant procedural complications occurred in 10 of 141 (7.1%) patients. Symptomatic intracranial hemorrhages was observed in 11 of 141 (7.8%) patients. Good neurological outcomes (modified Rankin score ≤2) were more frequent at 90 days in patients with successful recanalization compared with patients with unsuccessful recanalization (46% versus 10%; relative risk [RR], 4.4; 95% CI, 2.1 to 9.3; P<0.0001), and mortality was less (32% versus 54%; RR, 0.59; 95% CI, 0.39 to 0.89; P=0.01). Conclusions - A novel endovascular embolectomy device can significantly restore vascular patency during acute ischemic stroke within 8 hours of stroke symptom onset and provides an alternative intervention for patients who are otherwise ineligible for thrombolytics.

Original languageEnglish (US)
Pages (from-to)1432-1438
Number of pages7
JournalStroke
Volume36
Issue number7
DOIs
StatePublished - Jul 1 2005

Keywords

  • Angiography
  • Embolectomy
  • Embolism
  • Ischemia
  • Reperfusion
  • Stroke, acute
  • Thrombectomy
  • Treatment outcome

ASJC Scopus subject areas

  • Clinical Neurology
  • Cardiology and Cardiovascular Medicine
  • Advanced and Specialized Nursing

Fingerprint Dive into the research topics of 'Safety and efficacy of mechanical embolectomy in acute ischemic stroke: Results of the MERCI trial'. Together they form a unique fingerprint.

  • Cite this

    Smith, W. S., Sung, G., Starkman, S., Saver, J. L., Kidwell, C. S., Gobin, Y. P., Lutsep, H. L., Nesbit, G. M., Grobelny, T., Rymer, M. M., Silverman, I. E., Higashida, R. T., Budzik, R. F., & Marks, M. P. (2005). Safety and efficacy of mechanical embolectomy in acute ischemic stroke: Results of the MERCI trial. Stroke, 36(7), 1432-1438. https://doi.org/10.1161/01.STR.0000171066.25248.1d